Peritoneal dialysis solution for preventing and reducing peritoneal fibrosis
A technology of peritoneal dialysis fluid and fibrosis, which is applied in the direction of blood diseases, extracellular fluid diseases, anhydride/acid/halide active ingredients, etc. It can solve the problems of decreased ultrafiltration, failure to achieve therapeutic effect, and weakened dialysis effect. To achieve the effect of increased ultrafiltration function, decreased trend, and enhanced dialysis effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0022] The peritoneal dialysis solution for preventing and reducing peritoneal fibrosis described in this embodiment is weighed respectively by mass percentage: glucose 15g, sodium chloride 5.38g, calcium chloride 0.26g, magnesium chloride 0.051g, sodium lactate 4.48g, tranexamic acid 5g, water for injection 969.83mL, and the water for injection is divided into two parts of equal mass, which are respectively recorded as No. 1 water for injection and No. 2 water for injection; the glucose, tranexamic acid and No. The sodium chloride, calcium chloride, magnesium chloride, sodium lactate and No. 2 water for injection constitute liquid B; the liquids A and B constitute the peritoneal dialysis liquid.
Embodiment 2
[0024] The peritoneal dialysis solution for preventing and reducing peritoneal fibrosis described in this embodiment is weighed respectively by mass percentage: glucose 15g, sodium chloride 5.38g, calcium chloride 0.26g, magnesium chloride 0.051g, sodium lactate 4.48g, tranexamic acid 0.1g, 974.73mL of water for injection, and divide the water for injection into two parts of equal mass, which are respectively recorded as No. 1 water for injection and No. 2 water for injection; the glucose, tranexamic acid and No. 1 water for injection are composed of liquid A; The sodium chloride, calcium chloride, magnesium chloride, sodium lactate, and No. 2 water for injection are used to form liquid B, and the liquids A and B are used to form the peritoneal dialysis solution.
Embodiment 3
[0026] The peritoneal dialysis solution for preventing and reducing peritoneal fibrosis described in this embodiment is weighed respectively by mass percentage: glucose 15g, sodium chloride 5.38g, calcium chloride 0.26g, magnesium chloride 0.051g, sodium lactate 4.48g, tranexamic acid 1.5g, 973.33mL of water for injection, and divide the water for injection into two parts of equal mass, which are recorded as No. 1 water for injection and No. 2 water for injection; the glucose, tranexamic acid and No. 1 water for injection are composed of liquid A; The sodium chloride, calcium chloride, magnesium chloride, sodium lactate and No. 2 water for injection are used to form liquid B; the liquid A and liquid B are used to form the peritoneal dialysis solution.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 

